The Valley Desk

NCT00052377 · Interventional trial

Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov